How SAFE Notes Affect Your 409A Valuation

Short answer: Every outstanding SAFE note must be disclosed to your 409A appraiser and modeled in the OPM waterfall — omitting a SAFE invalidates the IRS safe harbor, and post-money SAFEs produce materially more common-stock dilution than pre-money SAFEs.

If you are about to grant your first options after a SAFE round and want a defensible report without the traditional-firm price tag, get your 409A report free — expert sign-off for IRS safe harbor is just $499, and the methodology handles pre-money and post-money SAFE stacks correctly out of the box.

How do SAFE notes affect your 409A valuation?

SAFE notes affect your 409A valuation by adding a convertible-security claim to the cap table that dilutes common stockholders when it converts. Even though a SAFE is not a priced round, it is a material equity issuance the appraiser must consider, and it must be modeled in the OPM backsolve waterfall to produce a defensible common stock FMV. Outstanding SAFEs generally lower common stock value and can lower it materially in stacked-SAFE situations.

The rest of this article goes deeper on the mechanics, the pre-money vs post-money distinction, the OPM treatment, and the documentation your appraiser needs to defend the report.

What Are SAFE Notes and Why Do They Matter for 409A?

A SAFE (Simple Agreement for Future Equity) is an unfunded equity claim — it gives an investor the right to receive shares at the next priced round, typically at a valuation cap, a discount, or both. Unlike a convertible note, it has no interest rate and no maturity date. For 409A purposes, the critical fact is that a SAFE is a real, enforceable claim on future equity that dilutes common stockholders when it converts.

Even though no shares have been issued and the SAFE has no fixed conversion price, the SAFE holder has a contractual right to receive shares at a defined trigger event. That contingent claim affects what common stockholders ultimately receive at exit — exactly what the 409A is measuring.

Are SAFE Notes Legally Required to Be Included in a 409A?

Yes. Treasury Regulations Section 1.409A-1(b)(5)(iv)(B)(1) requires the qualified appraiser to consider “all material information available about the company.” The AICPA Practice Aid treats outstanding convertible securities — including SAFE notes — as material. A 409A that ignores outstanding SAFEs does not qualify for the independent appraisal safe harbor.

How Does the Pre-Money vs. Post-Money SAFE Distinction Change Your 409A?

The pre-money vs post-money SAFE distinction is the single most consequential 409A modeling decision when SAFEs are involved. Y Combinator released two materially different SAFE templates: the original 2013 pre-money SAFE, and the 2018 post-money SAFE that is now the dominant form in the US market. The economic difference between them is non-trivial for 409A.

Pre-money SAFE. The original SAFE converts based on the pre-money valuation of the next priced round. Dilution from the SAFE conversion is shared among the existing shareholders and the new SAFE investor; the new priced-round investor receives the post-money percentage they bargained for, independent of what is happening with the SAFEs.

Post-money SAFE. The 2018 form locks in the SAFE investor's ownership percentage as of the SAFE closing date, measured against the post-money valuation. When additional SAFEs close at later dates, the new SAFEs do not dilute the earlier SAFE investors — all of the dilution falls on existing shareholders, primarily the common stockholders. This is why founders who close multiple post-money SAFEs are often surprised by how much common-stock dilution shows up at the next priced round.

For 409A purposes, the post-money SAFE produces materially more dilution to common stockholders than an economically equivalent pre-money SAFE. In stacked-SAFE situations — a startup with three to six outstanding post-money SAFEs at different caps — the common stock FMV in a properly modeled OPM backsolve can be 10–30% lower than the same situation modeled with pre-money SAFEs. This is not a methodology choice; it is a direct consequence of the SAFE economics, and any 409A that treats post-money SAFEs as if they were pre-money is producing an indefensibly high common stock value.

If your cap table has a mix of pre-money and post-money SAFEs — common for startups that raised over multiple periods — the 409A appraiser needs each SAFE document to determine the form. Section 1(d) of the standard YC SAFE document specifies whether it is pre- or post-money. Do not rely on the term sheet or the founder's memory; the actual executed SAFE is the only source of truth.

What Are the Two Main Methods for Valuing SAFE Notes in a 409A?

The AICPA-preferred approach is to model each SAFE as a separate convertible class in the OPM backsolve — with conversion logic that mirrors the actual SAFE document (cap, discount, MFN, pre- vs post-money). The OPM backsolve derives the implied total equity value and allocates it across all share classes, including SAFEs and common stock.

Some appraisers simplify by treating each SAFE as if it has already converted at the SAFE cap. This is acceptable for pre-revenue companies with one or two small SAFEs where the modeling difference is immaterial. For stacked-SAFE situations with multiple caps and post-money forms, the AICPA Practice Aid requires modeling the actual conversion terms — not the simplified conversion-at-cap shortcut.

If your 409A report is silent on SAFE methodology, ask. A defensible report states which method was used and why, and includes a sensitivity analysis if the choice materially affects common stock FMV. A report that lists SAFEs in the cap table but does not explain how they were modeled has a defensibility gap an IRS examiner will probe.

How Do SAFE Notes Interact with the OPM Backsolve Method?

When SAFEs are the only recent equity transaction, the OPM backsolve calibrates against the SAFE's investment amount and conversion terms rather than a fixed per-share price. This is more complex than a priced-round backsolve for three reasons:

• No fixed conversion price. The implied price-per-share depends on the cap and future round dynamics, both uncertain at the valuation date.
• MFN interaction. If a later SAFE closes at a lower cap, earlier SAFEs may automatically reset under their most-favored-nation provision — the appraiser must review each SAFE document.
• Non-arm's-length caps. Friends-and-family SAFEs often carry caps 30–50% below what an arm's-length investor would have accepted; the appraiser should apply a calibration adjustment.

A credible 409A provider with SAFE experience will document the calibration approach explicitly. A provider producing the same templated narrative regardless of whether SAFEs or preferred stock are present is producing a report that will not survive scrutiny.

Do you need to disclose SAFE notes to your 409A appraiser?

Yes — every outstanding SAFE note must be disclosed to the 409A appraiser, including SAFEs that have been signed but not yet wired and SAFEs from friends-and-family investors. The disclosure must include the executed SAFE document for each instrument, the wire date or expected wire date, the SAFE cap and discount, and whether the SAFE is pre-money or post-money. Treasury Regulations require the appraiser to consider all material information, and undisclosed SAFEs invalidate the safe harbor.

The intake check most credible 409A providers run on SAFE-funded startups looks like this:

• Executed SAFE documents for every outstanding SAFE. Not term sheets, not summaries, not a row in the cap table spreadsheet — the signed PDFs as they were executed by the company and the investor.
• The wire date or close date for each SAFE. A SAFE signed but not wired is still an enforceable claim; the appraiser typically includes it but flags the timing risk in the report.
• Cap, discount, and MFN terms for each SAFE. These should be in the executed document; double-check that the term sheet matches what was actually signed.
• Whether each SAFE is pre-money or post-money. Section 1(d) of the YC standard form specifies this; custom SAFEs need to be reviewed individually.
• Side letters and pro rata rights. Pro rata rights, MFN side letters, and any other ancillary agreements that modify the SAFE conversion economics must be disclosed.

Founders sometimes assume that “small” SAFEs — the $25K friends-and-family check from a former colleague — do not need to be disclosed. This is wrong. The materiality test is not about the size of the individual SAFE; it is about whether the SAFE is part of the company's cap table at the valuation date. A $25K SAFE on a pre-revenue company with $400K total raised is highly material to the cap table and to the common stock value. For more on SAFE-specific issues in early-stage valuations, see our coverage of 409A valuation after a SAFE round.

What Are the Most Common Mistakes Founders Make with SAFE Notes in 409A Valuations?

Six mistakes account for the vast majority of defective 409A valuations involving SAFE notes:

• Treating SAFEs as “not yet on the cap table.” SAFEs are convertible securities and must be included in the cap table for 409A purposes. They are not equity yet, but they represent enforceable claims on future equity.
• Confusing post-money and pre-money SAFEs. The form matters; the dilution math is different. Founders who close post-money SAFEs but model them as pre-money SAFEs end up with an inflated 409A.
• Omitting friends-and-family SAFEs. Every SAFE counts. A $10K SAFE from a college roommate is just as material to the cap table as a $250K SAFE from a venture firm.
• Forgetting MFN side letters. Side letters that modify SAFE economics (pro rata, MFN, information rights) need to be disclosed; they can change the conversion math.
• Not refreshing the 409A after a new SAFE closing. A material SAFE closing — particularly one at a higher or lower cap than the previous SAFE — is a material event under Treasury Regulations Section 1.409A-1(b)(5)(iv)(B)(2) that may invalidate the existing 409A safe harbor.
• Granting options before disclosing the SAFE round. If options are granted under a 409A that did not consider an outstanding SAFE round, the safe harbor on those grants is at risk; the IRS can argue the valuation did not consider all material information.

These mistakes are among the most common 409A compliance failures for early-stage startups. See our coverage of common 409A compliance mistakes for the broader founder error pattern.

Can a 409A be valid without including SAFE notes?

No — a 409A valuation that omits outstanding SAFE notes is not valid under the IRS safe harbor framework. Treasury Regulations Section 1.409A-1(b)(5)(iv)(B)(1) requires the appraiser to consider all material information; outstanding SAFEs are material by definition because they affect the cap table and the value of common stock. A 409A that ignores them fails the “considered all material information” prong of the safe harbor and shifts the burden of proof back to the taxpayer in an examination.

The practical risk: in an IRS Section 409A examination, the examiner will request the cap table contemporaneous with each option grant. If the cap table shows SAFEs that the 409A report does not mention or model, the report's safe harbor presumption is gone. The IRS does not need to prove the valuation was incorrect; the company simply loses the protective presumption and must affirmatively defend the strike price as having equaled fair market value at the grant date. Without the OPM modeling that should have included the SAFEs, that defense is difficult.

For the broader safe harbor framework that this requirement sits inside, see our coverage of the 409A safe harbor independent appraisal standard.

What Should Your 409A Report Document About SAFE Notes?

A defensible 409A report that handles SAFE notes correctly includes specific documentation that an IRS examiner or M&A due-diligence team can verify. Look for these items in the report when you receive it:

• SAFE inventory. A table listing every outstanding SAFE, with date, amount, cap, discount, MFN, and pre- vs post-money form. This is the appraiser's evidence that the SAFEs were considered.
• Methodology narrative. An explicit statement of which SAFE treatment method was used (separate convertible class in the OPM, or conversion-at-cap simplification) and why.
• Cap table reconciliation. A reconciliation showing how the SAFEs are modeled in the OPM relative to the executed SAFE documents — this is the appraiser's evidence that the modeling matches the actual SAFE terms.
• OPM waterfall with SAFE breakpoints. A breakpoint analysis that shows how the SAFE converts at different exit values; this is the heart of the OPM calculation when SAFEs are present.
• Sensitivity analysis. Where the SAFE treatment method materially affects common stock value, a brief sensitivity table showing the range of plausible FMVs under different assumptions.
• MFN and side-letter discussion. Where any SAFE has MFN provisions or side letters, the report should discuss how those provisions were considered.

A report that lacks these items but still purports to value a SAFE-funded company has a documentation gap that is fixable on revision — ask the appraiser to add the missing analysis before relying on the report for option grants. For the broader cap-table considerations that affect 409A modeling, see our coverage of how your cap table affects your 409A valuation and the related discussion of 409A valuation with convertible notes.

What Is the Bottom Line on SAFE Notes and Your 409A?

SAFE notes are not a 409A loophole. They are convertible securities that the IRS, Treasury Regulations, and AICPA Practice Aid treat as material to common stock valuation. A defensible 409A requires: full disclosure of every outstanding SAFE, correct pre- vs post-money modeling, OPM backsolve that respects actual conversion terms, and explicit documentation in the report.

Founders who get this right preserve the safe harbor on every grant. Those who get it wrong typically discover the problem during M&A due diligence or an IRS examination — long after the option grants are out and the cost of fixing the defect has multiplied.